With continual innovations in patient care delivery, organizations offering life sciences solutions must be simultaneously nimble while also navigating the complexities of the US and global healthcare systems. Pinnacle provides an array of services to support a variety of life sciences organizations, including medical device, pharmaceutical, biologic, and tissue companies. Our team of experts deliver comprehensive solutions for regulatory, quality, clinical, transactional, physician leadership, and key opinion leader advisory services. Pinnacle is a trusted advisor to US and global life science companies and works in collaboration with Pinnacle’s other service lines to provide an unparalleled range of consulting, valuation, and strategic services.
In addition to PHC’s valuation services pertaining to provider compensation, business, and real estate, our team of subject matter experts regularly perform fair market value analyses to support life sciences transactions. Our life sciences team ensure that we provide our clients with the highest level of expertise by remaining up to date on legal and regulatory issues affecting healthcare valuations, including the Stark Law, Anti-Kickback Statute, Office of Inspector General (OIG) advisory opinions, and the Physician Payments Sunshine Act. By remaining current on these matters, PHC’s life sciences team aims to provide thought leadership and provider relations services that protect life sciences companies from significant risks related to regulatory scrutiny. For instance, our process minimizes risks while maximizing the potential surrounding the proper alignment with the every-important Key Opinion Leaders (KOL) and Healthcare Professionals (HCP) within the life sciences space. By providing a thorough and effective third-party review of KOLs and HCPs, life sciences companies can better develop these alliances and use this information to determine fair market value compensation. In addition to these critical thought leader roles, our team regularly supports our clients’ other life sciences needs including strategic transactions, litigation support, implant & human cellular-based offerings, co-branding allocations between sponsoring companies and participating physician groups, intellectual property valuations, and more. Our collective goal continues to entail collaborating with clients such that they are better equipped to navigate a complex marketplace and understand the key information necessary to make informed, yet compliant, decisions.
Pinnacle’s experts provide an array of valuation and transaction services to support our clients in developing and marketing new life sciences innovations. As part of these efforts, we regularly perform assessments pertaining to matters such as:
With the ever-increasing rate of life sciences innovations, market participants must navigate critical decisions at a rapid pace to remain nimble and competitive. To assist our clients with this complex balance, Pinnacle offers life sciences companies the necessary consulting services to perform at a high level, resonate with investors, and achieve strategic goals. Our team of strategy consultants and financial experts work with life sciences companies by providing market research, analytical modeling, and financial advisory consulting to support strategic initiatives and identify new opportunities. The collective goal of these efforts is to provide the resources and expertise our clients need to improve operations and enhance financial outcomes. Regardless of the business cycle stage (i.e., start-up, commercialization, or exit), we assist clients in strengthening core components that improve internal performance and elevate external market value.
Pinnacle provides the necessary consulting services to assist clients in the life sciences arena with planning and achieving strategic objectives. These projects range across a broad array of subject matters and include activities such as: